Vitamin E regulates adipocytokine expression in a rat model of dietary-induced obesity.
The aim of this study was to determine the effect of the antioxidant vitamin E (VE) on adiponectin and leptin expression in obese rats. Thirty weaning male Sprague-Dawley rats were divided into three groups as follows: (1) a control group, fed with normal chow; (2) a diet-induced obesity group (DIO), fed with a high-fat diet and (3) an intervention group, fed with a high-fat diet supplemented with VE (350 mg/kg). After 10 weeks of being fed according to these group assignments, rats were weighed and euthanized. Blood and adipose tissues were then immediately collected; mRNA and protein levels of leptin and adiponectin were measured by realtime reverse transcription-polymerase chain reaction and Western blotting. Biomarkers of oxidative stress, including serum levels of 8-epi-prostaglandin-F(2)alpha (8-epi-PGF(2)alpha) and glutathione peroxidase activity, were also examined. Adiponectin and leptin levels were lower in the DIO group than in the control group. VE intervention increased the expression of both leptin and adiponectin (P values < 0.05). Association analysis showed that serum leptin levels correlated positively with body fat mass (r = 0.601, P < 0.05). Both serum leptin and adiponectin levels were associated with the presence of serum 8-epi-PGF2 alpha (leptin, r = 0.513, P < 0.05; adiponectin, r = -0.422, P < 0.05). Administration of VE decreases leptin and adiponectin expression in obese rats. This finding is consistent with the view that antioxidants can play an important role in the treatment of obesity-related diseases.
Shen
Xiu-Hua
XH
Clinical Nutrition Center, Shanghai XinHua Hospital, Shanghai 200092, China.
Tang
Qing-Ya
QY
Huang
Juan
J
Cai
Wei
W
D052242:Adiponectin / Q000097:blood* / Q000235:genetics*; D000273:Adipose Tissue / Q000378:metabolism / Q000473:pathology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001483:Base Sequence; D015415:Biomarkers / Q000097:blood; D017931:DNA Primers / Q000235:genetics; D004041:Dietary Fats / Q000008:administration & dosage; D015237:Dinoprost / Q000031:analogs & derivatives / Q000097:blood; D004195:Disease Models, Animal; D015870:Gene Expression / Q000187:drug effects; D005979:Glutathione Peroxidase / Q000097:blood; D020738:Leptin / Q000097:blood* / Q000235:genetics*; D008297:Male; D009765:Obesity / Q000097:blood* / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D018384:Oxidative Stress; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014810:Vitamin E / Q000494:pharmacology*; D015430:Weight Gain
D052242:Adiponectin; D000975:Antioxidants; D015415:Biomarkers; D017931:DNA Primers; D004041:Dietary Fats; D020738:Leptin; D012333:RNA, Messenger; D014810:Vitamin E; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost; D005979:Glutathione Peroxidase